Argenica Therapeutics prepares for phase one trial of neuroprotective drug
November 30, 2021
0ASX:AGN
Watch the video above for detailed insights and analysis.
Video Details
Featured Companies: ASX:AGN
Recorded: November 30, 2021
Stay Ahead
Get the latest market insights and analysis delivered to your inbox.